The rationale for possible targeted therapies in CMTC

Schematic illustration of the rationale for possible targeted therapies in CMTC. Blocking the constitutive activation of the Wnt/β-catenin signaling pathway could play an essential role in the treatment of CMTC through the degradation of β-catenin by stabilizing Axin2 (tankyrase inhibitors), CK1 agonists (SSTC3), inhibitors targeting β-catenin-TFC transcription complex (LF3), CBP inhibitors, as well as porcupine inhibitors, but data on clinical efficacy and safety are still insufficient. E2 via ER would have a tumor-promoting role through the PI3K/AKT/mTOR and the RAS/RAF/MAPK signaling pathways, which would justify treatment with both antiestrogens (tamoxifen and aromatase inhibitors) and MKI inhibitors. The detection of additional somatic events (e.g. RET rearrangements) could be subsidiary to treatment with specific inhibitors. CMTC, morular cribriform thyroid carcinoma; E2, estrogens; ER, estrogen receptors; MKI, multikinase; TCF/LEF, T-cell factor/lymphoid enhancer factor; CTNNB1, β-catenin 1; CCND1, cyclin D1; APC, APC regulator of WNT signaling pathway; CK1, casein kinase 1; GSK3β, glycogen synthase kinase 3β; DVL, disheveled; CBP, cyclic adenosine monophosphate responsive element binding protein 1 binding protein; LRP5/6, low-density lipoprotein receptor-related protein 5/6; PI3K, phosphatidylinositol 3-kinase, AKT, serine/threonine kinase; mTOR, mechanistic target of rapamycin kinase; RAS, small GTPase; RAF, Raf-1 proto-oncogene, serine/threonine kinase; MAPK, mitogen-activated protein kinase
The rationale for possible targeted therapies in CMTC

Publication

Cribriform morular thyroid carcinoma: Clinicopathological and molecular basis for both a preventive and therapeutic approach for a rare tumor (Review) (2024) Soledad Cameselle-García, et al. Oncol Rep. 2024 Sep;52(3). Figure: F4.

Gene mentions


Organism Group Word Match Source NCBI Symbol NCBI ID
Homo sapiens Primates DVL DVL ncbigene_synonym DVL1 1855
Homo sapiens Primates DVL DVL ncbigene_synonym DVL1P1 8215
Homo sapiens Primates DVL DVL famplex_relations DVL2 1856
Homo sapiens Primates DVL DVL famplex_relations DVL3 1857
Homo sapiens Primates Axin1 AXIN1 ncbigene_symbol AXIN1 8312
Homo sapiens Primates CK1 CK1 ncbigene_synonym CSNK1A1 1452
Homo sapiens Primates CK1 CK1 ncbigene_synonym KRT1 3848
Homo sapiens Primates CK1 CK1 ncbigene_synonym CSNK1A1L 122011
Homo sapiens Primates APC APC ncbigene_symbol APC 324
Homo sapiens Primates APC APC ncbigene_synonym PROC 5624
Homo sapiens Primates GSK3ẞ GSK3 famplex_relations GSK3A 2931
Homo sapiens Primates GSK3ẞ GSK3 famplex_relations GSK3B 2932
Homo sapiens Primates PTEN PTEN ncbigene_symbol PTEN 5728
Homo sapiens Primates PORCN PORCN ncbigene_symbol PORCN 64840
Homo sapiens Primates mTOR MTOR ncbigene_symbol MTOR 2475
Homo sapiens Primates RAS RAS famplex_relations KRAS 3845
Homo sapiens Primates RAS RAS famplex_relations HRAS 3265
Homo sapiens Primates RAS RAS famplex_relations NRAS 4893
Homo sapiens Primates GTP GTP ncbigene_synonym MTG1 92170
Homo sapiens Primates PI3K PI3K ncbigene_synonym PIK3CA 5290
Homo sapiens Primates PI3K PI3K ncbigene_synonym PIK3CB 5291
Homo sapiens Primates PI3K PI3K ncbigene_synonym PIK3CD 5293
Homo sapiens Primates PI3K PI3K ncbigene_synonym PIK3CG 5294
Homo sapiens Primates PI3K PI3K famplex_relations PIK3R3 8503
Homo sapiens Primates PI3K PI3K famplex_relations PIK3R4 30849
Homo sapiens Primates PI3K PI3K famplex_relations PIK3R5 23533
Homo sapiens Primates PI3K PI3K famplex_relations PIK3R6 146850
Homo sapiens Primates PI3K PI3K famplex_relations PIK3R1 5295
Homo sapiens Primates PI3K PI3K famplex_relations PIK3R2 5296
Homo sapiens Primates RET RET ncbigene_symbol RET 5979
Homo sapiens Primates BRAF BRAF ncbigene_symbol BRAF 673
Homo sapiens Primates MEK MEK ncbigene_synonym MAP2K7 5609
Homo sapiens Primates MEK MEK famplex_relations MAP2K1 5604
Homo sapiens Primates MEK MEK famplex_relations MAP2K2 5605
Homo sapiens Primates ERK ERK ncbigene_synonym EPHB2 2048
Homo sapiens Primates ERK ERK ncbigene_synonym MAPK1 5594
Homo sapiens Primates ERK ERK famplex_relations MAPK3 5595
Homo sapiens Primates CBP CBP ncbigene_synonym CREBBP 1387
Homo sapiens Primates CBP CBP ncbigene_synonym EIF4E 1977
Homo sapiens Primates CBP CBP ncbigene_synonym OPN1LW 5956
Homo sapiens Primates CBP CBP ncbigene_synonym PAG1 55824
Homo sapiens Primates CBP CBP ncbigene_synonym PCBP4 57060
Homo sapiens Primates TCF/LEF TCF ncbigene_synonym HNF4A 3172
Homo sapiens Primates MYC MYC ncbigene_symbol MYC 4609
Homo sapiens Primates CCND1 CCND1 ncbigene_symbol CCND1 595
Homo sapiens Primates STAT3 STAT3 ncbigene_symbol STAT3 6774
Homo sapiens Primates ELK1 ELK1 ncbigene_symbol ELK1 2002
Homo sapiens Primates ELK1 ELK1 ncbigene_synonym KCNH4 23415
Homo sapiens Primates ELK1 ELK1 ncbigene_synonym KCNH8 131096
Homo sapiens Primates FOS FOS ncbigene_symbol FOS 2353
Homo sapiens Primates FOS FOS famplex_relations FOSB 2354
Homo sapiens Primates FOS FOS famplex_relations FOSL1 8061
Homo sapiens Primates FOS FOS famplex_relations FOSL2 2355

Chemical mentions

Word Match MeSH Name ChEBI
Tamoxifen tamoxifen 2-{4-[(1Z)-1,2-diphenylbut-1-en-1-yl]phenoxy}-N,N-dimethylethanamine chebi:41774
Aromatase inhibitors aromatase inhibitors chebi:50790
inhibitors inhibitors inhibitor chebi:35222
inhibitors inhibitors inhibitor chebi:35222
MEK MEK butan-2-one chebi:28398

Disease mentions

Word Match MeSH Name DOID